Disease Domain | Count |
---|---|
Infectious Diseases | 5 |
Nervous System Diseases | 2 |
Neoplasms | 1 |
Hemic and Lymphatic Diseases | 1 |
Top 5 Drug Type | Count |
---|---|
Herbal medicine | 4 |
Small molecule drug | 3 |
Target- |
Mechanism- |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. CN |
First Approval Date17 Nov 2023 |
Target- |
Mechanism- |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. CN |
First Approval Date24 Aug 2020 |
Target |
Mechanism Hemoglobins modulators |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.- |
First Approval Date01 Jan 2011 |
Start Date02 Mar 2024 |
Sponsor / Collaborator |
Start Date08 Oct 2023 |
Sponsor / Collaborator |
Start Date05 Jul 2023 |
Sponsor / Collaborator |
Drug(Targets) | Indications | Global Highest Phase |
---|---|---|
Prilocaine Hydrochloride ( SCNA x VDCCs ) | Hyperemesis Gravidarum More | Approved |
Methylene blue ( Hemoglobins ) | Poisoning More | Approved |
Xiaoer douqiao Qingre Syrup | Common Cold More | Approved |
XiaoErChiQiaoQingRe | Influenza, Human More | Approved |
Xiaoer douqiao Qingre Granules(without sucrose) | Common Cold More | Approved |